Verified Nov 2026
Batteries & E-Mobility
·

Shanghai, Shanghai
·
Since 2000
WuXi AppTec is a global contract research, development, and manufacturing organization headquartered in Shanghai and founded in 2000. The company employs 38,000–39,000 people with estimated revenue of $5–10 billion. It serves pharmaceutical, biotech, automotive, and medical device sectors across 20 sites in Asia, Europe, and North America, providing integrated drug discovery, development, and manufacturing services to approximately 6,000 customers.
WuXi AppTec at a glance
Revenue
$5-10B
Est. band
Employees
10,000-50,000
Founded
2000
Headquarters
Shanghai, Shanghai
Import activity
7
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
7
Named foreign suppliers
2
Top origins
China · Republic of Korea

Shared foreign counterparties do not establish that these companies buy from WuXi AppTec.
What this tells a buyer
In 2026, WuXi AppTec increased capital expenditure to expand manufacturing capacity globally, with facility development spanning locations from Delaware to Singapore.
The company offers chemistry drug CRDMO, biology services, preclinical and clinical testing, API development and manufacturing, and complex conjugate synthesis across its network.
WuXi AppTec is dual-listed on the Shanghai and Hong Kong Stock Exchanges and serves a diverse client base ranging from early-stage biotech firms to large pharmaceutical companies.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
26 years in operation (founded 2000).
7 US import shipments on record.
Overview
WuXi AppTec is a global contract research, development, and manufacturing organization headquartered in Shanghai and founded in 2000. The company employs 38,000–39,000 people with estimated revenue of $5–10 billion. It serves pharmaceutical, biotech, automotive, and medical device sectors across 20 sites in Asia, Europe, and North America, providing integrated drug discovery, development, and manufacturing services to approximately 6,000 customers.
At a glance
Attribute | Detail |
|---|---|
Founded | 2000 |
Headquarters | Shanghai, Shanghai |
Employees | 10,000-50,000 |
Revenue | $5-10B (estimated) |
Primary capability | Batteries & E-Mobility |
What WuXi AppTec makes
The company offers chemistry drug CRDMO, biology services, preclinical and clinical testing, API development and manufacturing, and complex conjugate synthesis across its network.
Products and capabilities described on the company's own site include Extrusion, Coating (source: wuxiapptec.com).
Trade and customs footprint
In 2026, WuXi AppTec increased capital expenditure to expand manufacturing capacity globally, with facility development spanning locations from Delaware to Singapore. US customs bill-of-lading records list 7 inbound shipments across 2 foreign suppliers, with top origins including China · Republic of Korea.
Latest developments
2026-09-14 — Press Releases & Company Updates | WuXi AppTec (wuxiapptec.com)
2026-08-24 — WuXi AppTec Delivers Strong H1 2026 Results | WuXi AppTec (wuxiapptec.com)
2026-08-04 — WuXi AppTec boosts global capacity expansion with capital expenditure increase | Pharma Manufacturing (pharmamanufacturing.com)
2026-05-19 — WuXi AppTec Builds Global CRDMO Manufacturing Capacity (wuxiapptec.com)
2026-05-18 — WuXi AppTec Expands Global CRDMO Capacity — Delaware to Singapore (wuxiapptec.com)
2025-10-28 — WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health (wuxiapptec.com)
Facilities
WuXi AppTec is headquartered in Shanghai, Shanghai. Public sources also reference these locations:
Delaware — wuxiapptec.com
Middletown, Delaware — wuxiapptec.com
Couvet, Switzerland — wuxiapptec.com
Company details
WuXi AppTec is dual-listed on the Shanghai and Hong Kong Stock Exchanges and serves a diverse client base ranging from early-stage biotech firms to large pharmaceutical companies. WuXi AppTec was founded in 2000, has an estimated 10,000-50,000 employees, and is headquartered in Shanghai, Shanghai. On the LightSource stability read it is rated "Established & active": 26 years in operation (founded 2000). 7 US import shipments on record.
Frequently asked questions
What does WuXi AppTec make?
WuXi AppTec is a global contract research, development, and manufacturing organization headquartered in Shanghai and founded in 2000. The company employs 38,000–39,000 people with estimated revenue of $5–10 billion. It serves pharmaceutical, biotech, automotive, and medical device sectors across 20 sites in Asia, Europe, and North America, providing integrated drug discovery, development, and manufacturing services to approximately 6,000 customers.
Where is WuXi AppTec headquartered?
WuXi AppTec is headquartered in Shanghai, Shanghai.
When was WuXi AppTec founded?
WuXi AppTec was founded in 2000.
How big is WuXi AppTec?
WuXi AppTec has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).
Does WuXi AppTec import from overseas suppliers?
US customs bill-of-lading records show 7 inbound shipments for WuXi AppTec, with top origins including China · Republic of Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
